Skip to main content
OpenTrials

Clinical trial condition

Primary Myelofibrosis

Explore clinical trials studying Primary Myelofibrosis. Study availability and eligibility vary by location and protocol.

457 public trials 86 recruiting studies
Refine in advanced search Browse all conditions

Primary Myelofibrosis trial results

Recruiting

AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms

NCT05198960

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +24 more
Locations
  • CHU d'Angers Angers, France
  • CH d'Annecy Annecy, France
  • CH d'Argenteuil Argenteuil, France
  • CH d'Avignon Avignon, France
View all 42 locations
View Trial Details
Recruiting

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

NCT06859424

Conditions
AML (Acute Myelogenous Leukemia), Acute Leukemia (Category), Acute Lymphoid Leukemia (ALL), +36 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • Stanford Palo Alto, California, United States
  • University of Miami Miami, Florida, United States
View all 13 locations
View Trial Details
Recruiting

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

NCT06059391

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +34 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Northside Hospital Atlanta, Georgia, United States
  • DFCI/BWH Brigham and Women's Hospital Boston, Massachusetts, United States
View Trial Details
Recruiting

A New Diagnostic Algorithm to Non-invasively Track Fibrotic Changes in Myeloproliferative Neoplasms Based on C-C Chemokine Receptor 2 Detection. From Flow Cytometry to the Development of Targeted Positron Emission Tomography Molecular Imaging. Pre-clinical Studies and First In-human Proof of Concept

NCT07419178

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Dipartimento di Medicina e Chirurgia Parma, Italy
View Trial Details
Recruiting

A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia

NCT05980806

Conditions
Blood Platelet Disorders, Bone Marrow Diseases, Cytopenia, +8 more
Locations
  • City of Hope - Duarte Main Site Duarte, California, United States
  • Maryland Oncology Hematology - Independent of SCRI/ US Oncology Columbia, Maryland, United States
  • Weill Cornell Medicine NewYork-Presbyterian New York, United States
  • Duke University Durham, North Carolina, United States
View all 70 locations
View Trial Details
Recruiting

A Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis

NCT05037760

Conditions
Anemia, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Concord Hospital Concord, New South Wales, Australia
  • The Tweed Hospital Tweed Heads, New South Wales, Australia
  • Flinders Medical Centre Woodville South, South Australia, Australia
  • St. Vincents Hospital Melbourne Fitzroy, Victoria, Australia
View all 46 locations
View Trial Details

Related conditions